Chinese biotech shares surge as Big Pharma looks to license cancer treatments
- Posted on July 14, 2025
- By Financial Times
- 1 Views

Chinese biotech shares surge as Big Pharma looks to license cancer treatments

Sector returns are over 60% this year, with investors impressed by rapid pace of innovation